Collegium Pharmaceutical Inc., of Canton, Mass., reported cash and cash equivalents of $110.7 million, compared to $95.7 million at the end of last year. Net loss for the quarter was $24.5 million, or $1.05 per share (basic and diluted), as compared to net loss of $4.7 million, or 45 cents per share (basic and diluted), for the same period last year.